Html code here! Replace this with any non empty raw html code and that's it.

This common vitamin could cut your skin cancer risk in half

Date:

Share this article:

Del denne artikel:

A new large-scale study suggests that a simple, over-the-counter vitamin could play a major role in preventing skin cancer. Researchers found that taking vitamin B3 in the form of nicotinamide significantly reduced the risk of developing new cancers — especially for those who’ve already had one.

What the researchers found

Photo: Shutterstock.com

A massive U.S. study revealed that nicotinamide may lower the risk of skin cancer, particularly among people with a prior history of the disease.

A familiar vitamin with a new purpose

Photo: Shutterstock.com

Nicotinamide, a form of vitamin B3, has long been known to support healthy skin and help cells repair UV damage. Now it may prove to be a key tool in cancer prevention.

From small trials to big evidence

Photo: Shutterstock.com

Early studies from 2015 hinted at this benefit in just a few hundred participants. The new research, which included more than 33,000 patients, confirms those promising results on a much larger scale.

Also read: Study examines how artificial sweeteners affect weight and gut health

The strongest results in previous patients

Cancer,,Nurse,And,Help,With,Old,Woman,In,Hospital,For
Photo: Shutterstock.com

The study found that individuals who began taking nicotinamide after their first skin cancer diagnosis had a 54% lower risk of developing new cancers.

Noticeable overall reduction

Photo: Shutterstock.com

Overall, participants who took the vitamin showed a 14% lower risk of skin cancer compared with those who did not take it.

Especially effective against squamous cell carcinoma

Photo: Shutterstock.com

The strongest protective effect was seen against squamous cell carcinoma — one of the most common types of nonmelanoma skin cancer.

A shift in prevention strategies

Photo: Shutterstock.com

These findings could change how doctors approach prevention, encouraging earlier use of nicotinamide rather than waiting for multiple recurrences.

Also read: Scientists explore how vitamin D may shape long-term health

Not everyone benefits equally

Photo: Shutterstock.com

Researchers note that not all patients will experience the same protection. Roughly half of people who develop skin cancer go on to have multiple cases — those appear to benefit the most.

Limited results in transplant patients

Photo: Shutterstock.com

Among patients with weakened immune systems, such as organ transplant recipients, the protective effect was smaller but still showed some benefit against squamous cell carcinoma.

Simple, safe, and accessible

Photo: Shutterstock.com

Nicotinamide is inexpensive, well tolerated, and available without a prescription — making it a practical addition to skin cancer prevention for many adults.

What it means for you

Photo: Shutterstock.com

If you’ve had skin cancer before, talk to your doctor about whether nicotinamide could be right for you. And remember: consistent sun protection remains your best first defense.

Also read: An overview of early-stage pancreatic cancer symptoms

This article is based on information from ScienceDaily

Also read: What researchers found may finally help diabetics recover more naturally

Other articles

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.

New analysis: Six out of ten women may be overweight in 2050

Developments in women’s health point in a worrying direction. Cardiovascular diseases in particular may become more prevalent in the future.

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.